Submissions open until 10 August 2016
Submit to: email@example.com
WHO’s Department of Maternal, Newborn, Child and Adolescent Health and partners are conducting a research prioritization process on social, behavioural and community engagement interventions (SBCE) for maternal, newborn and child health (MNCH).
Social, behavioural and community engagement interventions are crucial for achieving the objectives of the Global Strategy for Women’s, Children’s, and Adolescent’s Health (2016–2030). However, there is still much that needs to be learned about which social, behavioural and community engagement interventions will have the desired impact and how they can best be implemented. Identifying the research that is most needed will help to direct future research so that it can fill the relevant knowledge gaps. We are asking individuals to help us identify top research needs for SBCE interventions in one of the following domains: maternal, newborn or child health. The period for submission of research needs will remain open until 10 August 2016.
If you would like to participate, please contact us at firstname.lastname@example.org and indicate your field of expertise—maternal, newborn or child, and your main activity: research or programme implementation. We will select participants according to participant recruitment criteria and quotas. If selected, we would then write to you to ask you to suggest the top 3 research needs in your area of expertise, and request generic information (organization affiliation, sex and country(ries) where you work) in a response box via email. Following the close of the period for submission, we will organize the responses received and contact you again via email to ask you to score the submitted research needs through an online survey. All names will be removed from the responses in the analysis and final report.
This research prioritization process is a collaboration between the World Health Organization, the United Nations Children’s Fund (UNICEF), the United Nations Population Fund (UNFPA), the United States Agency for International Development (USAID), the Norwegian Agency for International Development (NORAD), the Norwegian Institute of Public Health (NIPH) and the National Institute of Health (NIH).
Public consultation on the second EDCTP programme in 2014-2016
A public consultation regarding ‘the implementation of the Second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2) during the period 2014-2016’ was opened by the European Commission (EC) on 29 June 2016. It will close on 15 October 2016.
The consultation is open to all. Contributions from stakeholders and experts active in the field of clinical trials are particularly invited. An analysis of results will be published in February 2017. The views and opinions of stakeholders, experts active in the field and the wider public will contribute to the interim evaluation of the EDCTP2 programme. The interim evaluation is carried out by the EC with the assistance of independent experts. Interim evaluations are part of the monitoring of the programmes the European Union decided to support. Decision Nr 556/2014/EU of the European Parliament and of the Council of 15 May 2014 on the participation of the European Union in EDCTP2 stipulates (art. 34) that the EC should conduct interim evaluations of the programme.
The objective of this interim evaluation is “to assess the implementation of the EDCTP2 programme up to the present moment; to judge how recommendations from previous evaluations have been implemented; and to provide an outlook on what can be expected from EDCTP2 in the future”.
All information on the public consultation can be found on the website of the European Commission.
The U.S. Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada and the U.K.’s Department for International Development (DFID) invite global problem solvers to answer their fifth call for groundbreaking prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the time of childbirth with the launch of our Broad Agency Announcement (BAA).
Specifically, the challenge seeks to identify and develop transformative approaches that integrate new technologies, better service delivery models and improved “demand side” innovations that empower pregnant women and their families to practice healthy behaviors and be aware of and access health care during pregnancy, childbirth and the early postnatal period, especially the first two days after birth.
This year, in addition to the seed and transition awards used in previous rounds, the partners introduced a third funding stream. ‘Validation’ funds will be used to introduce and validate the effectiveness of innovations to reach proof-of-concept. Round 5 will also place an increased focus on advancing the most successful and transformational innovations as they transition to scale. The actual number of awards in each category varies.
The Challenge will be accepting applications starting February 16 through March 27, 2015 (closes at 2:00 p.m. EST).
Register before January 15th to get a discount and guaranteed accommodation
The 9th Conference on Global Health and Vaccination Research will take place at Hotel Clarion in Oslo 17-18 March 2015.The host of this year’s conference is the Interfaculty research programme – LEVE (Livelihoods in developing countries) at the University of Oslo. There will be a student conference at the University of Oslo 16 March.
The extended registration deadline is February 13th,
2015.Don’t hesitate, use this link
and register now!
Some of the confirmed key note speakers:
Rajendra Kumar Pachauri has been serving as the chairperson of theIntergovernmental Panel on Climate Change (IPCC) since 2002, which was awarded the Nobel Peace Prize in 2007 during his tenure.
H.R.H Crown Princess Mette-Marit of Norway will open the student conference. She is actively involved in HIV/AIDS-related work at the national and international level. In 2006, she was appointed Special Representative for UNAIDS.
Professor Hoosen Coovadia is Director of at MatCH (Maternal Adolescent & Child Health).
He is an internationally renowned and leading South African researcher in maternal and child health and has led ground-breaking research in mother-to-child transmission of HIV.
Alicia Yamin is a Lecturer on Global Health and Policy Director at the François-Xavier Bagnoud Center for Health and Human Rights at Harvard University. She has had a twenty-year career at the intersection of health, human rights, and development.
Professor Per Fugelli is a physician and professor of community medicine at the University of Oslo. He is one of Norway’s most frequent contributors to the public debate on public health, and has published and co-authored nearly 50 books.
Read more about the conference at the GlobVac website.